RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability

Insider Monkey published a list of worst 52-week low stocks, including RAPT Therapeutics, Inc. Amidst a 50 basis point interest rate cut by the Federal Reserve, the market is showing signs of recovery, especially in tech stocks.